Target intelligence / Profile preview

RNA, Ro-associated Y4 pseudogene 28 (RNY4P28)

Target
RNY4P28
Molecular classification
Other, Non-coding RNA, Pseudogene
01

Overview

RNA, Ro-associated Y4 pseudogene 28 (RNY4P28) is a human pseudogene located on chromosome 13 (chr13:60187738-60187830, hg38)[1]. It is categorized as a non-coding RNA pseudogene, specifically part of the Y RNA family. Y RNAs are small, evolutionarily conserved non-coding RNAs involved in RNA quality control, DNA replication initiation, and immune responses as components of Ro60 ribonucleoprotein complexes, but RNY4P28 does not code for a functional RNA or protein[1][3][4]. While the parent gene RNY4 and its related pseudogene fragments may appear in extracellular vesicles and exosomes and have been investigated as potential cancer biomarkers, there is no evidence that RNY4P28 itself acts as a direct therapeutic target or is functionally active in disease processes[2][3][4]. The true biological role, if any, of RNY4P28 remains to be demonstrated. RNY4 pseudogenes, including RNY4P28, are non-functional copies resulting from gene duplication events of the canonical RNY4 gene. RNY4 pseudogene fragments may be detected in sequencing studies but are not known to encode functional RNAs or proteins, nor do they possess known receptor, enzyme, or regulatory activity. No drugs are documented to interact with RNY4P28, and it is not a validated biomarker or known contributor to safety concerns in therapy.

Other names
RNY4 pseudogene 28RNY4P28RNA, Ro-associated Y4 pseudogene 28
02

Biological functions

Other (pseudogenes are generally non-functional copies of functional RNAs, but their fragments or expression can sometimes be detected)No established functional roleNon-functional copy of RNY4
03

Disease associations

Other (some Y RNA pseudogenes or fragments have been studied as potential biomarkers in specific cancers, but direct function for RNY4P28 is not established)No established direct functional role in disease processes
04

Biomarkers

Y RNA fragments (particularly related to parent gene RNY4 rather than RNY4P28 specifically)Considered for biomarker development in certain cancers (e.g., anaplastic large cell lymphoma, non-small cell lung cancer)RNY4P28 not specifically validated as a clinical biomarker

Beyond the preview

Go deeper on RNA, Ro-associated Y4 pseudogene 28 (RNY4P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 28 (RNY4P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call